HEMHOME

Defining regulators of hematopoietic stem cell homing and engraftment

 Coordinatore LUNDS UNIVERSITET 

 Organization address address: Paradisgatan 5c
city: LUND
postcode: 22100

contact info
Titolo: Dr.
Nome: Jens
Cognome: Forsberg
Email: send email
Telefono: +46046 222 0575
Fax: +46046 222 0568

 Nazionalità Coordinatore Sweden [SE]
 Totale costo 171˙828 €
 EC contributo 171˙828 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2009-IEF
 Funding Scheme MC-IEF
 Anno di inizio 2010
 Periodo (anno-mese-giorno) 2010-07-01   -   2013-02-24

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    LUNDS UNIVERSITET

 Organization address address: Paradisgatan 5c
city: LUND
postcode: 22100

contact info
Titolo: Dr.
Nome: Jens
Cognome: Forsberg
Email: send email
Telefono: +46046 222 0575
Fax: +46046 222 0568

SE (LUND) coordinator 171˙828.60

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

hsc    screen    regulate    blood    screens    cd    shrna    niche    cell    microscopy    shrnas    mscs    integrin    hscs    vivo    hspc    procedure    clinical    cells    regulators    hairpin    hspcs    adhesion    candidate    libraries    donor    bone    treatment    insufficient    efficiency    bmt    cyth    transplantation    marrow    hemhome    engraftment    homing    functional    hematopoietic    haematopoietic    molecules    rna    interference    molecule    adhesive    stem    interactions   

 Obiettivo del progetto (Objective)

'Transplantation of hematopoietic stem cells (HSC) is a life-saving treatment for many serious diseases. Unfortunately, the procedure is often hampered by insufficient numbers of donor stem cells and attempts to expand HSCs ex vivo prior to transplantation have remained unsuccessful. An important alternative, which significantly would reduce the required number of donor cells, is to enhance the engraftment efficiency of the transplanted HSCs. The aim of this project is to identify factors that regulate homing and adhesion of HSCs using an RNA interference based screening approach. The principle of the approach is to use lentiviral short-hairpin RNA (shRNA) libraries targeted to HSCs to screen for modifiers of cell adhesion. Adhesive interactions with extracellular matrix and surrounding cells, the so-called niche, are essential for HSC biology. Mesenchymal stroma cells (MSCs) will be used as a model for the adhesive interactions in the hematopoietic niche. When seeded on a layer of MSCs, the vast majority of human HSCs remain adherent to the MSCs. These highly adhesive properties of HSCs constitute a baseline for functional selection of shRNAs interfering with adhesion. Large numbers of HSCs will be targeted with pooled shRNA libraries and candidate shRNAs will be retrieved by functional selection of cells with reduced adhesive properties. The method has been standardized using shRNAs targeting the known mediator of cell adhesion, CD29 (β1 integrin). Knock down of CD29 in HSCs dramatically decreased their adhesion to MSCs. Candidate genes from the screens will be characterized for their role in homing and engraftment of HSCs by assays in vitro as well as in vivo through the ability to repopulate bone marrow of immundeficient NOD/SCID mice. Understanding the basic mechanisms that regulate homing and adhesion of HSCs to their niche is essential in order to develop strategies that may enhance the engraftment process in clinical settings.'

Introduzione (Teaser)

Bone marrow transplantation (BMT) is a procedure used for the treatment of blood and bone cancer. EU researchers have investigated how to make the procedure more efficient.

Descrizione progetto (Article)

A significant number of patients who would benefit from BMT or haematopoietic stem cell transplantation (HSCT) cannot receive treatment. Insufficient donor stem cells hampers the procedure. One excellent way to get over this problem is to enhance the engraftment efficiency. Engraftment is when new blood-forming cells start to grow and make healthy blood stem cells.

The 'Defining regulators of hematopoietic stem cell homing and engraftment' (HEMHOME) project has identified new molecules that mediate homing and adhesion of haematopoietic stem and progenitor cells (HSPCs) to their niche in the bone marrow. The microenvironment which interacts with stem cells to regulate cell fate is termed the stem cell niche.

The researchers successfully developed a short hairpin RNA-based screen to isolate possible candidate mediating molecules. Demonstrating feasibility of the approach, the screens detected known regulators of HSPC adhesion.

One promising molecule not previously investigated is cytohesin1 (CYTH1). Successful validation of CYTH1 in HSPC-niche interactions could mean it would be an ideal candidate to modulate the engraftment process in the clinic.

Using interference reflection microscopy in collaboration with the Immunology department in Lund University, the team has investigated exactly how CYTH1 alters the adhesive properties of HSPCs. Highly involved with cell-cell interaction, homing and colonisation, the scientists have looked at CYTH1-integrin activation status. Time-lapse microscopy can analyse movement of HSPCs with CYTH1 using random or shear stress.

Under the umbrella of regenerative medicine, stem cell therapy promises to be a critical element in health care of the future. The HEMHOME project has identified and validated a molecule that could be developed for clinical use in BMT.

Altri progetti dello stesso programma (FP7-PEOPLE)

GLOBHRM (2009)

Managing Global Human Resources in UK Multi National Corporations

Read More  

COMPBAND (2013)

Computational Studies of the Biogenic Amines of the Brain for Targeting Neurological Diseases

Read More  

ESFP (2011)

Equilibrium and Stability of Flowing Plasmas

Read More